N-of-1 Precision Medicine and Research Oversight

, , &
American Journal of Bioethics 19 (8):36-37 (2019)
  Copy   BIBTEX

Abstract

One of the concerns that citizen science shares with the evolving practice of precision medicine is how to approach oversight for N-of-1 or N-of-many-1’s research. In their target article, Wiggins...

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2019.1619871

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Commentary: Who's Afraid of the RAC? Lessons from the Oversight of Controversial Science.Jeffrey P. Kahn - 2009 - Journal of Law, Medicine and Ethics 37 (4):685-687.
Gene Therapy Oversight: Lessons for Nanobiotechnology.Susan M. Wolf, Rishi Gupta & Peter Kohlhepp - 2009 - Journal of Law, Medicine and Ethics 37 (4):659-684.
Revolution or Reform in Human Subjects Research Oversight.Steven Joffe - 2012 - Journal of Law, Medicine and Ethics 40 (4):922-929.
Beyond Consent: Building Trusting Relationships With Diverse Populations in Precision Medicine Research.Stephanie A. Kraft, Mildred K. Cho, Katherine Gillespie, Meghan Halley, Nina Varsava, Kelly E. Ormond, Harold S. Luft, Benjamin S. Wilfond & Sandra Soo-Jin Lee - 2018 - American Journal of Bioethics 18 (4):3-20.
Four Paradigms of Clinical Research and Research Oversight.Ezekiel J. Emanuel & Christine Grady - 2007 - Cambridge Quarterly of Healthcare Ethics 16 (1):82-96.
The Precision Medicine Nation.Maya Sabatello & Paul S. Appelbaum - 2017 - Hastings Center Report 47 (4):19-29.
Thought Leader Perspectives on Participant Protections in Precision Medicine Research.Catherine M. Hammack, Kathleen M. Brelsford & Laura M. Beskow - 2019 - Journal of Law, Medicine and Ethics 47 (1):134-148.
Henry K. Beecher and the Oversight of Research in Children.John Lantos - 2016 - Perspectives in Biology and Medicine 59 (1):95-106.
Commentary: Emerging Technologies Oversight: Research, Regulation, and Commercialization.Robbin Johnson - 2009 - Journal of Law, Medicine and Ethics 37 (4):587-593.
Reflections on Governance Models for the Clinical Translation of Stem Cells.Jeremy Sugarman - 2010 - Journal of Law, Medicine and Ethics 38 (2):251-256.
The historical foundations of the research-practice distinction in bioethics.Tom L. Beauchamp & Yashar Saghai - 2012 - Heoretical Medicine and Bioethics 33 (1):45-56.
Precision Medicine Research: An Exception or An Exemplar?Emily A. Largent - 2019 - Journal of Law, Medicine and Ethics 47 (1):149-151.
Commentary: Evaluating Oversight of Human Drugs and Medical Devices.Susan Bartlett Foote - 2009 - Journal of Law, Medicine and Ethics 37 (4):629-632.
Moving Beyond Compliance: Measuring Ethical Quality to Enhance the Oversight of Human Subjects Research.Holly Taylor - 2007 - IRB: Ethics & Human Research 29 (5).
Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine.Alessandro Blasimme & Effy Vayena - 2016 - BMC Medical Ethics 17 (1):67.

Analytics

Added to PP
2019-07-25

Downloads
15 (#923,100)

6 months
2 (#1,232,442)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Add more references